Petrylak DP, Balar AV, O'Donnell PH, et al. EV-201: Results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and immune checkpoint inhibitors. ASCO Annual Meeting 2019, abstract LBA4505.
I-SPY2: voordeel van toevoegen pembrolizumab aan neoadjuvante chemotherapie
mrt 2020 | Borstkanker